Venous thrombotic events in patients treated with immune checkpoint inhibitors for non-small cell lung cancer: A retrospective multicentric cohort study
出版年份 2021 全文链接
标题
Venous thrombotic events in patients treated with immune checkpoint inhibitors for non-small cell lung cancer: A retrospective multicentric cohort study
作者
关键词
Non-small cell lung cancer, Immunotherapy, Checkpoint inhibitors, Thrombosis, Pulmonary embolism, Deep vein thrombosis
出版物
THROMBOSIS RESEARCH
Volume 205, Issue -, Pages 29-39
出版商
Elsevier BV
发表日期
2021-06-29
DOI
10.1016/j.thromres.2021.06.018
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- An overview of thrombotic complications of old and new anticancer drugs
- (2020) Marcel Levi et al. THROMBOSIS RESEARCH
- Incidence, risk factors and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy
- (2020) Florian Moik et al. BLOOD
- Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
- (2019) Alok A. Khorana et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
- (2019) Filipe Martins et al. Nature Reviews Clinical Oncology
- Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials
- (2019) Yucai Wang et al. JAMA Oncology
- Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
- (2019) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients
- (2019) Federico Nichetti et al. Cancers
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
- (2018) Marina Chiara Garassino et al. LANCET ONCOLOGY
- Immune checkpoint inhibitors and cardiovascular toxicity
- (2018) Alexander R Lyon et al. LANCET ONCOLOGY
- Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
- (2018) Marc Carrier et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- (2017) Achim Rittmeyer et al. LANCET
- iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
- (2017) Lesley Seymour et al. LANCET ONCOLOGY
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
- (2017) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meta-analysis on anticoagulation and prevention of thrombosis and mortality among patients with lung cancer
- (2017) H.E. Fuentes et al. THROMBOSIS RESEARCH
- Venous Thromboembolism in Patients Diagnosed With Lung Cancer
- (2016) E. Salla et al. ANGIOLOGY
- Cross Talk Pathways Between Coagulation and Inflammation
- (2016) Jonathan H. Foley et al. CIRCULATION RESEARCH
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
- (2016) Roy S Herbst et al. LANCET
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Venous thromboembolism and lung cancer: a review
- (2015) Carolina Vitale et al. MULTIDISCIPLINARY RESPIRATORY MEDICINE
- Prevalence and Associations of VTE in Patients With Newly Diagnosed Lung Cancer
- (2014) Yuhui Zhang et al. CHEST
- 30-Year Mortality After Venous Thromboembolism
- (2014) Kirstine Kobberøe Søgaard et al. CIRCULATION
- Programmed Cell Death-1 Deficiency Exacerbates T Cell Activation and Atherogenesis despite Expansion of Regulatory T Cells in Atherosclerosis-Prone Mice
- (2014) Clément Cochain et al. PLoS One
- Risk of venous and arterial thromboembolic events associated with anti-EGFR agents: a meta-analysis of randomized clinical trials
- (2012) F. Petrelli et al. ANNALS OF ONCOLOGY
- A Systematic Review of Pulmonary Embolism in Patients With Lung Cancer
- (2012) Rafael D. Malgor et al. ANNALS OF THORACIC SURGERY
- Risk of Venous Thromboembolism in Patients With Cancer Treated With Cisplatin: A Systematic Review and Meta-Analysis
- (2012) Sonia Seng et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence and predictors of venous thromboembolism (VTE) among ambulatory patients with lung cancer
- (2012) G.C. Connolly et al. LUNG CANCER
- Impairment of the Programmed Cell Death-1 Pathway Increases Atherosclerotic Lesion Development and Inflammation
- (2011) De-xiu Bu et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- High Incidence of Thromboembolic Events in Patients Treated With Cisplatin-Based Chemotherapy: A Large Retrospective Analysis
- (2011) Russell A. Moore et al. JOURNAL OF CLINICAL ONCOLOGY
- Lung cancer associated venous thromboembolic disease: A comprehensive review
- (2011) Luis Corrales-Rodriguez et al. LUNG CANCER
- Prediction of venous thromboembolism in cancer patients
- (2010) C. Ay et al. BLOOD
- Risk of Arterial Thromboembolic Events With Sunitinib and Sorafenib: A Systematic Review and Meta-Analysis of Clinical Trials
- (2010) Toni K. Choueiri et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study
- (2010) Lucio Crinò et al. LANCET ONCOLOGY
- Venous thromboembolism and prognosis in cancer
- (2010) Alok A. Khorana THROMBOSIS RESEARCH
- Clinical Predictors for Fatal Pulmonary Embolism in 15 520 Patients With Venous Thromboembolism
- (2008) Silvy Laporte et al. CIRCULATION
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients
- (2008) Shobha Rani Nalluri et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Multicenter, Phase II Trial of Sunitinib in Previously Treated, Advanced Non–Small-Cell Lung Cancer
- (2008) Mark A. Socinski et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started